Archive for August, 2008

OMNI Postings of 8/31/08

On this date in 1842, U.S. Naval Observatory was authorized by an act of Congress.  Now why anybody would spend taxpayers money to observe navels, I’ll never understand.
But I digress… 

1)  Here’s another recall because of Listeria fears.  Kinda like Listeria Hysteria!  It’s Cracked Pepper Style Smoked Salmon and it’s sold in Ohio.  More info is in the post.
2)  This CHEST abstract deals with unstable PE patients (in extremis) who either failed thrombolysis or couldn’t have it.  Instead of resorting to surgical embolectomy, these patients underwent catheter-directed intervention (CDI).  A roto-rooter went up to the clot and fragmented it and sucked it out with or without a little local thrombolytic.  Ten of 12 patients (83%) survived and remained stable until hospital discharge.  Any hospital around here have that capability?
3)  This is an Op-Ed piece about a guy (John Goodman, an influential figure in Republican health care circles) who said that no one really in uninsured.  The “uninsured” can always go to the ER.  That’s what he said and the ACEP president had a few things to say about that.
4)  This abstract says that more than 10 million Americans are taking opioid medications to treat their pain and more than four million of them use them  regularly.  The majority are located in NW Ohio, seems like.
5)  This is a press release from WHO.  No, not the nocturnal avian creature that eats mice.  The World Health Organization.  After a 3-year investigation WHO said that the toxic combination of bad policies, economics, and politics is, in large measure responsible for the fact that a majority of people in the world do not enjoy the good health that is biologically possible.  WHO points out, for example, in the United States, 886 202 deaths would have been averted between 1991 and 2000 if mortality rates between white and African Americans were equalized. (This contrasts to 176 633 lives saved in the US by medical advances in the same period.) This is all contained in their tome: Closing the Gap in a Generation: Health Equity through Action on the Social Determinants of Health.
Enjoy the sun,
Paul R.

Chronic Cough & Familial Stress

Julie M. Marchant, Peter A. Newcombe, Elizabeth F. Juniper, Jeannie K. Sheffield, Stephen L. Stathis, and Anne B. Chang
Chest Aug 2008: 303–309. Prepublished online July 18, 2008; 

ABSTRACT 

Background: The burden of children’s chronic cough to parents is largely unknown. The objectives of this study were as follows: (1) to determine the burden of chronic cough using a purposely designed questionnaire, and (2) to evaluate psychological (child’s anxiety and parental emotional distress) and other influences on the reported burden of cough.

Methods: Parents of children newly referred for chronic cough completed three questionnaires (Spence anxiety scale; depression, anxiety, and stress 21-item scale [DASS]; and burden of cough questionnaire) at enrollment. The last 79 parents also completed these questionnaires at follow-up.

Results: Median age of the 190 children recruited was 2.6 years. The number of medical consultations for coughing illness in the last 12 months was high: > 80% of children had >5 doctor visits and 53% had > 10 visits. At presentation, burden scores correlated to parental DASS scores when their child was coughing. Stress was the largest contributor to parents’ emotional distress. Parental anxiety and depression scores were within published norms. Scores on all three DASS subscales reduced significantly when the children ceased coughing. At follow-up, the reduction in burden scores was significantly higher in the “ceased coughing” group (n = 49) compared to the “still coughing” group (n = 32).

Conclusions: Chronic cough in children is associated with a high burden of recurrent doctor visits, parental stress, and worries that resolve when cough ceases. Parents of children with chronic cough did not have above-average anxiety or depression levels. This study highlights the need to improve the management of children with chronic cough, including clinicians being cognizant of the emotional distress of the parents.

Yellow nail syndrome (YNS)

Fabien Maldonado, Henry D. Tazelaar, Chih-Wei Wang, and Jay H. Ryu
Chest Aug 2008: 375–381.

ABSTRACT

Background: Yellow nail syndrome (YNS) is a rare condition defined by the presence of yellow nails associated with lymphedema and/or chronic respiratory manifestations. Several aspects of this disorder remain poorly defined.

Methods: We sought to clarify the clinical features and course associated with YNS by analyzing 41 consecutive cases evaluated at a tertiary referral medical center.

Results: There were 20 men and 21 women; median age at diagnosis was 61 years (range, 18 to 82 years). None had a family history of YNS. All but one patient had chronic respiratory manifestations that included pleural effusions (46%), bronchiectasis (44%), chronic sinusitis (41%), and recurrent pneumonias (22%); 26 patients (63%) had lymphedema. Treatment included rotating antibiotic therapy for bronchiectasis, thoracenteses, oral vitamin E, and corticosteroid therapy. Eight patients underwent surgical management of recurrent pleural effusions including pleurodesis and decortication; two additional patients underwent pleurodesis via tube thoracostomy. The yellow nails improved or resolved in 14 of 25 patients (56%) for whom relevant data were available. Median survival of this cohort using the Kaplan-Meier method was 132 months, significantly lower than (p = 0.01) the control population. Among those still alive (20 patients), the disease appeared stable.

Conclusions: In most cases, YNS is an acquired disorder and associated respiratory manifestations are generally manageable with a regimen of medical and surgical treatments. Yellow nails improve in about one half of patients, often without specific therapy.

Massive PE & Options

William T. Kuo, Maurice A. A. J. van den Bosch, Lawrence V. Hofmann, John D. Louie, Nishita Kothary, and Daniel Y. Sze
Chest Aug 2008: 250–254.
ABSTRACT

Purpose: The standard medical management for patients in extremis from massive pulmonary embolism (PE) is systemic thrombolysis, but the utility of this treatment relative to catheter-directed intervention (CDI) is unknown. We evaluated the effectiveness of CDI as part of a treatment algorithm for life-threatening PE.

Methods: A retrospective review was performed on 70 consecutive patients with suspected acute PE over a 10-year period (from 1997 to 2006) who had been referred for pulmonary angiography and/or intervention. The criteria for study inclusion were patients who received CDI due to angiographically confirmed massive PE and hemodynamic shock (shock index, > 0.9). CDI involved suction embolectomy and fragmentation with or without catheter thrombolysis.

Results: Twelve patients were treated with CDI. There were seven men and five women (mean age, 56 years; age range, 21 to 80 years). Seven patients (58%) were referred for CDI after failing systemic infusion with 100 mg of tissue plasminogen activator, and five patients (42%) had contraindications to systemic thrombolysis. Catheter-directed fragmentation and embolectomy were performed in all patients (100%). Additionally, catheter-guided thrombolysis was performed in eight patients (67%). Technical success was achieved in 12 of 12 cases (100%). There were no major procedural complications (0%). Significant hemodynamic improvement (shock index, < 0.9) was observed in 10 of 12 cases (83%). The remaining two patients (17%) died secondary to cardiac arrest within 24 h. Ten of 12 patients (83%) survived and remained stable until hospital discharge (mean duration, 20 days; range, 3 to 51 days).

Conclusion: In the setting of hemodynamic shock from massive PE, CDI is potentially a life-saving treatment for patients who have not responded to or cannot tolerate systemic thrombolysis.

Smoked Salmon Recall

FOR IMMEDIATE RELEASE –BELLINGHAM, WASHINGTON – August 29, 2008 – Trans-Ocean Products, Inc. of Bellingham, Washington is recalling its 4 ounce Cracked Pepper Style Smoked Salmon Lot No 54933-2 because it has the potential to be contaminated with Listeria monocytogenes, an organism, which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.

Cracked Pepper Style Smoked Salmon, 4 ounce packages were distributed to three supermarket chains in seven states: Brookshire Brothers in Texas and Louisiana; Price Choppers in New York, Pennsylvania, Massachusetts and Vermont; and Giant Eagle in Ohio and Pennsylvania.

The product is sliced cold-smoked salmon with black pepper. It is vacuum packaged in a resealable purple plastic pouch and bears the brand name Trans Ocean Products.The lot number is ink jetted on the back panel of the package, just right of center.

No illnesses have been reported to date in connection with this problem.

The potential for contamination was noted after routine testing by Trans-Ocean Products revealed the presence of Listeria monocytogenes in one 4 ounce package of Cracked Pepper Style Smoked Salmon.

Distribution of the product has been suspended while the FDA and Trans-Ocean Products investigate the source of the problem.

Consumers that have purchased Trans Ocean ProductsCracked Pepper Style Smoked Salmon are urged to return them to the place of purchase for a full refund.

Consumers with questions may contact Trans-Ocean Products. Call (800) 290-2722 Monday – Friday 6AM to 5PM. Over the Labor Day weekend call (360) 739-4181.

OMNI Postings of 8/30/08

On this date in 1862, The Yankees were defeated by the Rebs at the Second Battle of Bull Run.  The score was 8-4.  John McCain was a bat-boy.
But I digress…
1)  This news story is coming out of the UK, but the next stop may be in your hospital.  Apparently in the hospital, there are computerized verbal prompts that remind you to wash your hands before you touch a patient.  Big Brother…all in the name of good infection control practices.  Why stop there?  Why not have a verbal prompt as you get off the toilet.  “Hey, buddy…did you forget to use toilet paper?”
2)  There is a recall going on about Landshire’s American Sub sandwich.  It’s sold in Ohio and the fear is that there might be Listeria.  You know, short term high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea (You know, kinda like what you feel after a meal at The Toledo Club).  However, Listeria infection can also cause miscarriages and stillbirths, especially if you’re pregnant.  No illnesses have been reported.  This post itemizes what specific products to look out for.  
3)  This British Columbia abstract from J Amer Geriatr Soc  looked at how antipsychotic medication influenced death in the elderly population.  Those on conventional  antipsychotic medication had a higher risk of death due to cardiovascular diseases, respiratory diseases, & nervous system diseases.  But at least they died sane.  If this happened to Elwood P. Dowd, we wouldn’t have had Harvey.
4)  This Acad Emerg Med abstract concerns itself about how depression is assessed in ERs.  Of 871 audiorecorded ED visits, 70 (8%) included discussions containing any reference to depression and 20 (2%) constituted significant depression discussions. I’m not surprised.  One reason is that if it’s not the reason the patient came in then why look for bad news.  The second reason probably concerns itself with once you find out the patient may be depressed then what do you do with the patient?  If we have the dog chase its tail on this one, then don’t complain about ER waits.
5)  This abstract from Preventive Cardiology studied a bunch of kids (mean age <4 yrs.) over a long period of time and discovered that dietary intake influences CV disease risk factors in childhood.  Increasing body mass index (BMI), waist circumference at Follow Up, and intake of sucrose at Follow Up were inversely associated with high-density lipoprotein cholesterol levels at Follow Up. Waist circumference and BMI at Follow Up were associated with higher triglyceride levels, while percent energy from monounsaturated fat was associated with lower values.  The little porkers won't live to see twenty!  Why do I bring this up?  Simple.  Every once in a while we'll see a little kid who looks like a stand-in for Jabba The Hut.  It would be nice to educate the parents about the health ramifications of stuffing their kid like a goose at Thanksgiving. 
6)  Thought you might like to see a graph showing life expectancy around the world.  It’s interesting that the average life expectancy in the U.S. is 75 years while that of the average black person in Washington, D.C. is 63 years.  Is it because of violence, access to medical care, or the toxic manure emanating from Congress?  Or a little bit of all 3?
Ta-ta,
Paul R.

Who’s really uninsured? No one?

Intro:  the following comes from a NY Times Op-Ed piece by  Paul Krugman.(http://www.nytimes.com/2008/08/29/opinion/29krugman.html?_r=1&ref=opinion&oref=slogin).  In response to Goodman’s alleged comments, Dr. Linda Lawrence, president of the American College of Emergency Physicians, said, “Access to care in the emergency department is no substitute for the comprehensive healthcare reform policy that should be at the heart of the platform of any presidential campaign.”

Op-Ed:  “…Last week John Goodman, an influential figure in Republican health care circles, explained that we shouldn’t worry about the growing number of Americans without health insurance, because there’s no such thing as being uninsured. After all, you can always get treatment at an emergency room. And Mr. Goodman — he’s the president of the National Center for Policy Analysis, an important conservative think tank, and is often described as the “father of health savings accounts,” a central feature of the Bush administration’s health policy — wants the next president to issue an executive order prohibiting the Census Bureau from classifying anyone as uninsured. “Voilà!” he says. “Problem solved.”

The truth, of course, is that visiting the emergency room in a medical crisis is no substitute for regular care. Furthermore, while a hospital will treat you whether or not you can pay, it will also bill you — and the bill won’t be waived unless you’re destitute. As a result, uninsured working Americans avoid visiting emergency rooms if at all possible, because they’re terrified by the potential cost: medical expenses are one of the prime causes of personal bankruptcy.

Mr. Goodman has in the past, including in an op-ed for The Wall Street Journal, described himself as an adviser to the McCain campaign on health policy. The campaign now claims that he is not, in fact, an adviser. But it’s a good bet that Mr. McCain’s inner circle shares Mr. Goodman’s views.

You see, Mr. Goodman’s assertion that lack of health insurance is no problem precisely echoed what President Bush said a year ago: “I mean, people have access to health care in America. After all, you just go to an emergency room.” That’s because both men — like Mr. Gramm — were just saying in public what modern Republicans say when they talk to each other. Despite attempts to feign sympathy, the leaders of today’s G.O.P. fundamentally feel that Americans complaining about their economic and health care difficulties are, well, just a bunch of whiners…”

Unbranded product advertising

Wall Street Journal (8/29, B1, Mundy) reports that “‘unbranded product advertising’…is gaining popularity among drugmakers, which in recent months have come under renewed fire from lawmakers for the ways in which they promote drugs directly to consumers.” Unbranded advertising is a form of advertising where a product is not directly named in the commercial. “Under Food and Drug Administration (FDA) rules, if an ad doesn’t directly name the drug, it doesn’t have to include the reading of possible side effects that can chew up expensive television time.” Pfizer uses this form of advertising for its antismoking drug Chantix (varenicline). For its part, Pfizer “says it isn’t pushing Chantix in its ads, or trying to circumvent FDA rules.” The goal of the ad, a spokesperson said, “is to encourage people to quit smoking.”

Americans & Opioids

Intro:  This abstract says that more than 10 million Americans are taking opioid medications to treat their pain and more than four million of them use them  regularly.

ABSTRACT (http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T0K-4S26K63-1&_user=10&_coverDate=03%2F14%2F2008&_alid=782778710&_rdoc=1&_fmt=high&_orig=search&_cdi=4865&_sort=d&_docanchor=&view=c&_ct=1&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=b02f73a22a88b1672cc8a8185562d115)

Title: Prevalence and characteristics of opioid use in the US adult population

Pain, In Press, Corrected Proof, Available online 14 March 2008,
Judith Parsells Kelly, Suzanne F. Cook, David W. Kaufman, Theresa Anderson, Lynn Rosenberg and Allen A. Mitchell  

 This report describes the prevalence of opioid use in the US adult population, overall and in subgroups, the characteristics of opioid use, and concomitant medication use among opioid users. Data were obtained from the Slone Survey, a population-based random-digit dialing survey. One household member was randomly selected to answer a series of questions regarding all medications taken during the previous week. There were 19,150 subjects aged greater-or-equal, slanted18 interviewed from 1998 to 2006. Opioids were used ‘regularly’ (greater-or-equal, slanted5 days per week for greater-or-equal, slanted4 weeks) by 2.0%; an additional 2.9% used opioids less frequently. Regular opioid use increased with age, decreased with education level, and was more common in females and in non-Hispanic whites. The prevalence of regular opioid use increased over time and was highest in the South Central region. Nearly one-fifth of regular users had been taking opioids for greater-or-equal, slanted5 years. Concomitant use of greater-or-equal, slanted10 non-opioid medications was reported by 21% of regular opioid users compared to 4.5% of subjects who did not use opioids. Regular opioid users were more likely to use stool softeners/laxatives (9% vs. 2%), proton pump inhibitors (25% vs. 8%), and antidepressants (35% vs. 10%). From this nationally-representative telephone survey, we estimate that over 4.3 million US adults are taking opioids regularly in any given week. Information on the prevalence and characteristics of use is important as opioids are one of the most widely prescribed classes of drugs in the US.

A. Fib and no warfarin

MedPage Today, 8/28/08 (http://www.medpagetoday.com/Cardiology/Strokes/tb/10713):  “About 60% of patients with a first stroke and a history of atrial fibrillation were not receiving warfarin at the time of hospital admission, according to an audit of 12 hospitals in Canada. Furthermore, three-fourths of those who were taking warfarin received a subtherapeutic dose…”

Gladstone D, et al “Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated” Stroke 2008; DOI: 10.1161/strokeaha.108.516344.

ABSTRACT:

Background and Purpose—Warfarin is the most effective stroke prevention medication for high-risk individuals with atrial fibrillation, yet it is often underused. This study examined the magnitude of this problem in a large contemporary, prospective stroke registry.

Methods—We analyzed data from the Registry of the Canadian Stroke Network, a prospective database of consecutive patients with stroke admitted to 12 designated stroke centers in Ontario (2003 to 2007). We included patients admitted with an acute ischemic stroke who (1) had a known history of atrial fibrillation; (2) were classified as high risk for systemic emboli according to published guidelines; and (3) had no known contraindications to anticoagulation. Primary end points were the use of prestroke antithrombotic medications and admission international normalized ratio.

Results—Among patients admitted with a first ischemic stroke who had known atrial fibrillation (n=597), strokes were disabling in 60% and fatal in 20%. Preadmission medications were warfarin (40%), antiplatelet therapy (30%), and no antithrombotics (29%). Of those taking warfarin, three fourths had a subtherapeutic international normalized ratio (<2.0) at the time of stroke admission. Overall, only 10% of patients with acute stroke with known atrial fibrillation were therapeutically anticoagulated (international normalized ratio ≥2.0) at admission. In stroke patients with a history of atrial fibrillation and a previous transient ischemic attack or ischemic stroke (n=323), only 18% were taking warfarin with therapeutic international normalized ratio at the time of admission for stroke, 39% were taking warfarin with subtherapeutic international normalized ratio, and 15% were on no antithrombotic therapy.

Conclusions—In high-risk patients with atrial fibrillation admitted with a stroke, and who were candidates for anticoagulation, most were either not taking warfarin or were subtherapeutic at the time of ischemic stroke. Many were on no antithrombotic therapy. These findings should encourage greater efforts to prescribe and monitor appropriate antithrombotic therapy to prevent stroke in individuals with atrial fibrillation.
 

Antipsychotic Drugs & The Risk of Stroke

Healthday, 8/28/08 (http://www.healthday.com/Article.asp?AID=618886)

All antipsychotic drugs can increase the risk of stroke, but the risk is greatest among older patients with dementia, British researchers report.

Concerns about the risk of stroke and antipsychotics were first raised in 2002, especially in people with dementia. In 2004, Britain’s Committee on Safety of Medicines recommended that antipsychotics not be used in people with dementia. And, in 2005, the U.S. Food and Drug Administration ordered manufacturers of atypical antipsychotics to add a black box warning to their products about the increased risk for stroke.

“Antipsychotics are effective in treating potentially very distressing psychiatric symptoms, but as with all drugs, their use can be associated with a range of benefits and possible side effects,” said study author Dr. Ian Douglas, a research fellow at the London School of Hygiene and Tropical Medicine. “This study has further clarified the potential for antipsychotics to increase the risk of stroke.”

Both typical (first generation) and atypical (second generation) antipsychotics are associated with an increased risk of stroke, Douglas said. “This risk is substantially higher in patients with dementia than those without. These findings need to be factored into prescribing decisions made by doctors caring for patients with often-distressing and difficult-to-treat psychiatric symptoms.”

For the study, Douglas and his colleague Liam Smeeth, a professor of clinical epidemiology, collected data on 6,790 patients who had suffered a stroke and were taking antipsychotic drugs. Patients taking antipsychotic drugs were 1.7 times more likely to have a stroke, and patients with dementia taking antipsychotics were 3.5 times more likely to have a stroke.

The risk for stroke was slightly higher for people taking the newer atypical antipsychotics, compared with people taking the older typical antipsychotics. Atypical antipsychotics include drugs such as Abilify, Clozaril and Zyprexa. Typical antipsychotics include Thorazine, Haldol and Clopixol.

The study authors did not look at the potential mechanisms associated with antipsychotics that cause stroke, or why the risk appears higher with atypical antipsychotics.

“We believe that the risks associated with antipsychotic use in patients with dementia generally outweigh the potential benefits, and, in this patient group, use of antipsychotic drugs should be avoided wherever possible,” Douglas said. “For other patients, careful consideration must be given to the likely individual risks and benefits of any prescribing decision.”

The findings were published online Aug. 29 in the British Medical Journal.

Business Week: On Balanced Billing

Business Week, 8/28/08 (http://www.businessweek.com/magazine/content/08_36/b4098040915634.htm): As health-care costs continue to soar, millions of confused consumers are paying medical bills they don’t actually owe. Typically this occurs when an insurance plan covers less than what a doctor, hospital, or lab service wants to be paid. The health-care provider demands the balance from the patient. Uncertain and fearing the calls of a debt collector, the patient pays up.

Most consumers don’t realize it, but this common practice, known as balance billing, often is illegal. When doctors or hospitals think an insurer has reimbursed too little, state and federal laws generally bar the medical providers from pressuring patients to pay the difference. Instead, doctors and hospitals should be wrangling directly with insurers. Economists and patient advocates estimate that consumers pay $1 billion or more a year for which they’re not responsible.

Yolanda Fil, a 59-year-old McDonald’s  cashier in Maple Shade, N.J., got tangled up with balance billing after gall bladder surgery in 2005. She and her husband, Leon, a retired state transportation worker, have coverage through Horizon Blue Cross Blue Shield of New Jersey. Horizon made payments on Fil’s behalf to the hospital, surgeon, and anesthesiologist. Then, in 2006, Vanguard Anesthesia Associates billed Fil for an unpaid balance of $518. Soon, a collection agency hired by Vanguard started calling Fil once a week, she says. Although she thought her co-payment and insurance should have covered the surgery, Fil eventually paid the $518, plus a $20 transaction fee. “I didn’t have any choice,” she says. “They threatened me with bad credit.”

CAUGHT IN THE MIDDLE

Luckily for Fil, her insurer decided to get tough with Vanguard. In December 2006, Horizon Blue Cross sued the medical practice for balance billing Fil and more than 8,000 other policyholders who received invoices for a total of $4.3 million for service from 2004 to 2006. A New Jersey judge last year ordered Vanguard to stop billing the patients and provide refunds to those who had paid. Fil is awaiting her $538 refund. Vanguard didn’t respond to requests for comment.

National statistics aren’t available, but there’s little doubt that many consumers unwittingly fall victim to balance billing. The California Association of Health Plans, a trade group in Sacramento, estimates that 1.76 million policyholders in that state received such bills in the past two years, totaling $528 million. The group found that 56% paid the bills. “Patients think they owe this money, and it causes tremendous stress and anxiety for people,” says Cindy Ehnes, director of the California Managed Health Care Dept. “It is inappropriate to put the patient in the middle of this.”

Balance billing most frequently occurs when medical providers participating in a managed-care network believe the plan’s insurer is imposing too deep a discount on medical bills or is taking too long to pay. California, New Jersey, and 45 other states ban in-network providers from billing insured patients beyond co-payments or co-insurance required by the plan. Similarly, federal law prohibits providers from billing Medicare patients for unpaid balances.

These laws require medical providers to seek payment only from the insurer for services covered by the plan. Many states also shield insured patients from balance billing by out-of-network hospitals and doctors in emergencies, since patients usually don’t control who treats them in those situations. (Bans on balance billing generally don’t apply when a patient gets an elective procedure, such as cosmetic surgery, or seeks out-of-network, non-emergency service without a referral.)

Some physicians, hospitals, and labs take advantage of consumer befuddlement, argues Jane Cooper, CEO of Patient Care, a Milwaukee firm that employers hire to help insured workers fight billing mistakes. “Medical providers count on the fact people will pay these bills because they don’t have time to figure it out,” Cooper says.

Quest Diagnostics, the country’s largest lab chain, with revenue last year of $6.7 billion, has faced investigations and lawsuits over allegations of balance billing. A private suit that seeks class-action status in federal court in Newark, N.J., alleges that Quest has balance-billed thousands of patients covered by private insurance and Medicare, turning over many accounts to debt collectors. Quest, based in Madison, N.J., denies any wrongdoing.

In a separate case in 2003, the New York Attorney General’s Office alleged that Quest encouraged consumers to overpay or billed them after Quest had already been paid by insurers. The company denied wrongdoing in the New York case and said only five people were due modest refunds. Quest agreed to pay New York $150,000 in legal costs and revise some practices, such as waiting longer to dun patients while a claim is pending with an insurer. A Quest spokeswoman says: “The vast majority of our transactions occur problem-free when correct information is provided by patients, physicians, and payers.”

As some authorities get tougher, physicians are trying to overturn prohibitions on balance billing. The American Medical Assn. is lobbying Congress to allow balance billing within the Medicare program, as was allowed until 1991. Two Republican congressmen, Tom Feeney of Florida and Tom Price of Georgia, have sponsored legislation that would accomplish that goal. The AMA cites declining reimbursements from Medicare and private insurers in support of its bid to bill patients directly. AMA member David McKalip, a neurosurgeon in St. Petersburg, Fla., says patients can trust doctors to behave ethically and not gouge the poor: “Doctors will know up front which patients are willing to pay” beyond what the government reimburses.

FIGHTING BACK

Consumers overwhelmed by medical bills might dispute that. Many lack the resources to fight balance billing on their own. With an eye on their legal fees, private attorneys hesitate to take on individual disputes over amounts that usually don’t exceed $1,000. Glenn Siglinger is one exception. He fought a lengthy battle against a surgeon all the way to the Connecticut Supreme Court. In 2006 that court upheld a trial verdict awarding the Siglinger family nearly $40,000 in punitive damages from a doctor.

The case began in December 1995, when Siglinger’s wife, Laura, and his daughter, Allison, then three, were injured in a car accident. Both were taken to the emergency room at Bridgeport Hospital, where Dr. Charles Gianetti, the plastic surgeon on call, stitched a cut on Allison’s face. The Siglingers’ insurer paid Gianetti $1,981 under a contract with the family’s health plan. Later in 1996, he claimed the Siglingers owed him an unpaid balance of $4,496. The Siglingers refused to pay, and Gianetti sued them. Ruling for the Siglingers, the trial judge ordered Gianetti to pay their legal fees, in addition to the punitive damages. The Siglingers say he hasn’t paid them anything.

“It was traumatic enough seeing my daughter go through a serious accident, but then to go through this,” says Siglinger, a real estate investor. He and his wife have since divorced; Allison is now 15. “I wonder how many people paid these bills without giving it a second thought,” he says. The Siglingers are among 150 patients Gianetti has sued for unpaid balances, according to state records. The Connecticut Attorney General’s Office is scheduled to go to trial next year against Gianetti, having accused him in a civil suit of improper billing.

Gianetti, 69, no longer practices medicine, but he continues to pursue former patients in court. He says the state of Connecticut has “nothing on me,” declining other comment.

Even routine office visits can lead to balance billing. In Illinois, federal prosecutors say Dr. Janet Despot and Rickey Weir, her husband and office manager at the Cardinal Respiratory medical practice in Springfield, overbilled Medicare, private insurers, and patients by more than $800,000 from 1997 through 2007. Despot, 50, pleaded guilty to a misdemeanor charge of balance-billing Medicare patients in February. She didn’t receive jail time, but has paid a $10,000 fine and forfeited $2.5 million that will be used for restitution and additional fines. Federal officials are considering barring her from the Medicare program; the Illinois medical board separately is seeking to discipline her. For now she remains in business.

William Gass, a 41-year-old recycling coordinator, successfully took Despot to small-claims court in 1999 to get $300 in improper bills erased from his credit report. “It’s unconscionable to me she can still practice medicine,” Gass says.

Despot says her husband, Weir, from whom she is getting divorced, handled all billing. She claims she wasn’t aware that patients were being hounded for money they didn’t owe. A Medicare ban “would end my career,” she says. “I didn’t understand medical billing.” Weir has pleaded not guilty to fraud charges and awaits trial in November. He declined to comment.

Regulators in most states have been slow to take action in billing disputes. But in July, California officials sued Prime Healthcare Services, seeking to force the 12-hospital chain based in Victorville, Calif., to stop balance billing. Last September, Thomas Lai was rushed to the emergency room at Prime’s Huntington Beach Hospital because of severe chest pain. The 51-year-old musician stayed for four days, but doctors didn’t find anything seriously wrong.

His wife, Tess, says she asked the hospital staff to transfer Thomas to a hospital covered by his Kaiser Permanente network—but to no avail. She had taken him to the hospital closest to home, which Kaiser advised her to do. Kaiser paid a discounted rate for the hospitalization, and the Lais thought that was the end of it.

They were shocked to receive a bill from Prime in May for more than $16,000. A collection firm threatened to report them to credit agencies. “I’m concerned about our credit report with this huge bill hanging over us,” Tess says. Kaiser instructed the Lais not to pay anything while the state case unfolds.

Asked about the state action, Prime said: “This frivolous suit is not about the actions of one provider but the failure of the [state] to do its job to regulate HMOs and provide assistance to providers who have the right to be reimbursed properly for emergency services rendered to HMO enrollees.” Prime didn’t comment on the Lais.

Cindy Ehnes, the director of California’s managed-care department, says her agency isn’t taking sides between providers and insurers. It holds insurers accountable for paying promptly, she says. Medical providers should use proper channels to press their claims, such as an independent dispute-resolution system crafted by the state, she adds. “Patients are having their credit destroyed at a time when they are already sick and vulnerable.”

Life Expectancy Around the World

 

              1

WHO: Inequities Kill

WHO Press Release, 8/29/08 (http://www.who.int/mediacentre/news/releases/2008/pr29/en/print.html):

28 August 2008 | GENEVA — A child born in a Glasgow, Scotland suburb can expect a life 28 years shorter than another living only 13 kilometres away. A girl in Lesotho is likely to live 42 years less than another in Japan. In Sweden, the risk of a woman dying during pregnancy and childbirth is 1 in 17 400; in Afghanistan, the odds are 1 in 8. Biology does not explain any of this. Instead, the differences between - and within - countries result from the social environment where people are born, live, grow, work and age.

These “social determinants of health” have been the focus of a three-year investigation by an eminent group of policy makers, academics, former heads of state and former ministers of health. Together, they comprise the World Health Organization’s Commission on the Social Determinants of Health. Today, the Commission presents its findings to the WHO Director-General Dr Margaret Chan.

“(The) toxic combination of bad policies, economics, and politics is, in large measure responsible for the fact that a majority of people in the world do not enjoy the good health that is biologically possible,” the Commissioners write in Closing the Gap in a Generation: Health Equity through Action on the Social Determinants of Health. “Social injustice is killing people on a grand scale.”

“Health inequity really is a matter of life and death,” said Dr Chan today while welcoming the Report and congratulating the Commission. “But health systems will not naturally gravitate towards equity. Unprecedented leadership is needed that compels all actors, including those beyond the health sector, to examine their impact on health. Primary health care, which integrates health in all of government’s policies, is the best framework for doing so.”

Sir Michael Marmot, Commission Chair said: “Central to the Commission’s recommendations is creating the conditions for people to be empowered, to have freedom to lead flourishing lives. Nowhere is lack of empowerment more obvious than in the plight of women in many parts of the world. Health suffers as a result. Following our recommendations would dramatically improve the health and life chances of billions of people.”

 

Inequities within countries

 

Health inequities – unfair, unjust and avoidable causes of ill health – have long been measured between countries but the Commission documents “health gradients” within countries as well. For example:

 

  • Life expectancy for Indigenous Australian males is shorter by 17 years than all other Australian males.
  • Maternal mortality is 3–4 times higher among the poor compared to the rich in Indonesia. The difference in adult mortality between least and most deprived neighbourhoods in the UK is more than 2.5 times.
  • Child mortality in the slums of Nairobi is 2.5 times higher than in other parts of the city. A baby born to a Bolivian mother with no education has 10% chance of dying, while one born to a woman with at least secondary education has a 0.4% chance.
  • In the United States, 886 202 deaths would have been averted between 1991 and 2000 if mortality rates between white and African Americans were equalized. (This contrasts to 176 633 lives saved in the US by medical advances in the same period.)
  • In Uganda the death rate of children under 5 years in the richest fifth of households is 106 per 1000 live births but in the poorest fifth of households in Uganda it is even worse – 192 deaths per 1000 live births – that is nearly a fifth of all babies born alive to the poorest households destined to die before they reach their fifth birthday. Set this against an average death rate for under fives in high income countries of 7 deaths per 1000.

 

The Commission found evidence that demonstrates in general the poor are worse off than those less deprived, but they also found that the less deprived are in turn worse than those with average incomes, and so on. This slope linking income and health is the social gradient, and is seen everywhere – not just in developing countries, but all countries, including the richest. The slope may be more or less steep in different countries, but the phenomenon is universal.

 

Wealth is not necessarily a determinant

 

Economic growth is raising incomes in many countries but increasing national wealth alone does not necessarily increase national health. Without equitable distribution of benefits, national growth can even exacerbate inequities.

While there has been enormous increase in global wealth, technology and living standards in recent years, the key question is how it is used for fair distribution of services and institution-building especially in low-income countries. In 1980, the richest countries with 10% of the population had a gross national income 60 times that of the poorest countries with 10% of the world’s population. After 25 years of globalization, this difference increased to 122, reports the Commission. Worse, in the last 15 years, the poorest quintile in many low-income countries have shown a declining share in national consumption.

Wealth alone does not have to determine the health of a nation’s population. Some low-income countries such as Cuba, Costa Rica, China, state of Kerala in India and Sri Lanka have achieved levels of good health despite relatively low national incomes. But, the Commission points out, wealth can be wisely used. Nordic countries, for example, have followed policies that encouraged equality of benefits and services, full employment, gender equity and low levels of social exclusion. This, said the Commission, is an outstanding example of what needs to be done everywhere.

 

Solutions from beyond the health sector

 

Much of the work to redress health inequities lies beyond the health sector. According to the Commission’s report, “Water-borne diseases are not caused by a lack of antibiotics but by dirty water, and by the political, social, and economic forces that fail to make clean water available to all; heart disease is caused not by a lack of coronary care units but by lives people lead, which are shaped by the environments in which they live; obesity is not caused by moral failure on the part of individuals but by the excess availability of high-fat and high-sugar foods.” Consequently, the health sector – globally and nationally – needs to focus attention on addressing the root causes of inequities in health.

“We rely too much on medical interventions as a way of increasing life expectancy” explained Sir Michael. “A more effective way of increasing life expectancy and improving health would be for every government policy and programme to be assessed for its impact on health and health equity; to make health and health equity a marker for government performance.”

 

Recommendations

 

Based on this compelling evidence, the Commission makes three overarching recommendations to tackle the “corrosive effects of inequality of life chances”:

 

  • Improve daily living conditions, including the circumstances in which people are born, grow, live, work and age.
  • Tackle the inequitable distribution of power, money and resources – the structural drivers of those conditions – globally, nationally and locally.
  • Measure and understand the problem and assess the impact of action.

 

 

Recommendations for daily living

 

Improving daily living conditions begins at the start of life. The Commission recommends that countries set up an interagency mechanism to ensure effective collaboration and coherent policy between all sectors for early childhood development, and aim to provide early childhood services to all of their young citizens. Investing in early childhood development provides one of the best ways to reduce health inequities. Evidence shows that investment in the education of women pays for itself many times over.

Billions of people live without adequate shelter and clean water. The Commission’s report pays particular attention to the increasing numbers of people who live in urban slums, and the impact of urban governance on health. The Commission joins other voices in calling for a renewed effort to ensure water, sanitation and electricity for all, as well as better urban planning to address the epidemic of chronic disease.

Health systems also have an important role to play. While the Commission report shows how the health sector can not reduce health inequities on its own, providing universal coverage and ensuring a focus on equity throughout health systems are important steps.

The report also highlights how over 100 million people are impoverished due to paying for health care – a key contributor to health inequity. The Commission thus calls for health systems to be based on principles of equity, disease prevention and health promotion with universal coverage, based on primary health care.

 

Distribution of resources

 

Enacting the recommendations of the Commission to improve daily living conditions will also require tackling the inequitable distribution of resources. This requires far-reaching and systematic action.

The report foregrounds a range of recommendations aimed at ensuring fair financing, corporate social responsibility, gender equity and better governance. These include using health equity as an indicator of government performance and overall social development, the widespread use of health equity impact assessments, ensuring that rich countries honour their commitment to provide 0.7% of their GNP as aid, strengthening legislation to prohibit discrimination by gender and improving the capacity for all groups in society to participate in policy-making with space for civil society to work unencumbered to promote and protect political and social rights. At the global level, the Commission recommends that health equity should be a core development goal and that a social determinants of health framework should be used to monitor progress.

The Commission also highlights how implementing any of the above recommendations requires measurement of the existing problem of health inequity (where in many countries adequate data does not exist) and then monitoring the impact on health equity of the proposed interventions. To do this will require firstly investing in basic vital registration systems which have seen limited progress in the last thirty years. There is also a great need for training of policy-makers, health workers and workers in other sectors to understand the need for and how to act on the social determinants of health.

While more research is needed, enough is known for policy makers to initiate action. The feasibility of action is indicated in the change that is already occurring. Egypt has shown a remarkable drop in child mortality from 235 to 33 per 1000 in 30 years. Greece and Portugal reduced their child mortality from 50 per 1000 births to levels nearly as low as Japan, Sweden, and Iceland. Cuba achieved more than 99% coverage of its child development services in 2000. But trends showing improved health are not foreordained. In fact, without attention health can decline rapidly.

 

Is this feasible?

 

The Commission has already inspired and supported action in many parts of the world. Brazil, Canada, Chile, Iran, Kenya, Mozambique, Sri Lanka, Sweden, and the UK have become ‘country partners’ on the basis of their commitment to make progress on the social determinants of health equity and are already developing policies across governments to tackle them. These examples show that change is possible through political will. There is a long way to go, but the direction is set, say the Commissioners, the path clear.

WHO will now make the report available to Member States which will determine how the health agency is to respond.

Kids & Cardiovascular Diseases

MedWire, 8/29/08 )http://www.medwire-news.md/news/article.aspx?k=438&id=77325):  The dietary intake of preschool children influences presence and severity of cardiovascular disease (CVD) risk factors, such as serum lipids and body weight, over time, show results published in the journal Preventive Cardiology.

Childhood Diet, Overweight, and CVD Risk Factors: The Healthy Start Project

Cardiovascular disease (CVD) risk factors can be identified in children and tracked over time. We studied 519 children (mean age, 3.9 years) and reevaluated CVD risk factors 4 years later. Baseline and follow-up (FU) measures included height, weight, body mass index (BMI), blood pressure level, blood lipid values, and 24-hour dietary intake. Nutritional predictors of CVD risk factors (lipid levels and BMI) were identified using regression analysis at follow-up. Energy intake at baseline and FU, as well as increasing BMI over time, were directly associated with total cholesterol levels. Dietary intake of monounsaturated fat and dietary fiber were significant predictors of total cholesterol level at follow-up (inverse associations). Increasing BMI, waist circumference at FU, and intake of sucrose at FU were inversely associated with high-density lipoprotein cholesterol levels at FU. Waist circumference and BMI at FU were associated with higher triglyceride levels, while percent energy from monounsaturated fat was associated with lower values. This study provides further evidence that dietary intake influences CVD risk factors in childhood. (Prev Cardiol. 2008;11:11–20)